Industry News
Life Sciences
Top stories summarized by our editors
7/23/2021

Quidel has begun a Lyme disease awareness campaign focused on the risk of getting the tick-borne infection as Americans send their children to summer camp. Quidel, which makes the Sofia 2 Lyme FIA test, has targeted camp directors and counselors to remind them to promote rapid testing for early detection to make treatment more effective.

Full Story:
FiercePharma
7/23/2021

State and local health officials are using persuasion and education campaigns instead of mask mandates and restrictions to encourage people to get COVID-19 vaccinations after cases have surged due to the Delta variant. Arkansas Gov. Asa Hutchinson banned new mask mandates but asked residents to get vaccinated, and said the state is increasing its marketing campaign to reach populations with low vaccination rates.

7/23/2021

-- Marty O'Halloran, global chief executive at DDB, commenting for a story at The Drum about advertising agency staffing.

7/23/2021

Danaher generated $7.2 billion in sales and $1.7 billion in profits during its fiscal second quarter, which ended July 2. "We continued to make significant growth investments during the quarter, strengthening our organic growth trajectory and enhancing our portfolio with the announcement of our pending acquisition of Aldevron," said Rainer Blair, president and CEO of Danaher.

Full Story:
MassDevice (Boston)
7/23/2021

The Modulus anterior lateral interbody fusion implant, made from 3D-printed titanium, has been released by NuVasive.

Full Story:
Becker's Spine Review
7/23/2021

Abbott generated $10.2 billion in sales and $1.2 billion in profits during its fiscal second quarter, which ended June 30. "Excluding COVID testing-related sales, our sales grew more than 11 percent on an organic basis compared to pre-pandemic levels in the second quarter of 2019, which demonstrates the fundamental strength of our performance," said Robert Ford, Abbott's CEO and president.

Full Story:
MassDevice (Boston)
More Summaries:
Robert Ford
7/23/2021

To fix weaknesses in the medical device supply chain, the FDA is urging congress to provide it with more funding and authority to collect information about device shortages. "To ensure the U.S. is properly prepared now, and in the future, we must take action to secure our medical device supply chain, including related materials, parts, and components," wrote Janet Woodcock, the FDA acting commissioner.

Full Story:
Healthcare Dive
7/23/2021

The FDA has given 510(k) clearance to ZOLL Medical for a traumatic brain injury software on its Propaq MD monitor/defibrillator and Propaq M monitor.

Full Story:
FDAnews
7/23/2021

A recall of Philips ventilators and breathing devices last month has been classified as Class 1 by the FDA. There have been 83 complaints linked to the recalled devices, but no deaths or injuries have been reported, the FDA said.

Full Story:
Reuters
7/23/2021

European regulators have given CE mark certification to Congenica for its genomic interpretation software that is also called Congenica. The platform conducts a rapid analysis of genomic data to detect rare hereditary genomic disorders in patients.

Full Story:
FDAnews
More Summaries:
Congenica